title: Rituximab for patients with nephrotic syndrome--authors' reply.
authors.affiliation: Department of Pediatrics, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan. Electronic address: iijima@med.kobe-u.ac.jp.
authors.forename: Kazumoto
authors.initials: K
authors.lastname: Iijima
authors.affiliation: Division for Clinical Trials, Department of Development Strategy, Centre for Social and Clinical Research, National Research Institute for Child Health and Development, Tokyo, Japan.
authors.forename: Mayumi
authors.initials: M
authors.lastname: Sako
authors.affiliation: Department of Pediatrics, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan.
authors.forename: Kandai
authors.initials: K
authors.lastname: Nozu
authors.affiliation: Division for Clinical Trials, Department of Development Strategy, Centre for Social and Clinical Research, National Research Institute for Child Health and Development, Tokyo, Japan.
authors.forename: Hidefumi
authors.initials: H
authors.lastname: Nakamura
authors.affiliation: Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: Shuichi
authors.initials: S
authors.lastname: Ito
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D005938:Glucocorticoids; D007166:Immunosuppressive Agents